SF646 (Legislative Session 94 (2025-2026))

Licensee fee reduction for manufacturers and wholesalers of medical gas

AI Generated Summary

The bill SF No 646 proposes amendments to the current licensing fees for health-related occupations, particularly targeting those engaged in the manufacturing and wholesaling of medical gases in Minnesota. The primary change outlined in the bill is to reduce the license fee for drug wholesalers and manufacturers dealing with medical gases. Specifically, the initial licensing fee for the first facility remains at $5,500, but the fee for each additional facility is reduced from $500 to $260. This legislation aims to adjust fees to potentially encourage more business activity or alleviate financial burdens in the specific sector of the health industry.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
January 26, 2025HouseFloorActionIntroduction and first reading
January 26, 2025SenateFloorActionIntroduction and first reading
January 26, 2025SenateFloorActionReferred toHealth and Human Services
January 26, 2025HouseFloorActionReferred toHealth and Human Services
January 26, 2025SenateFloorActionReferred toHealth and Human Services
January 29, 2025SenateFloorActionAuthor added
January 29, 2025SenateFloorActionAuthor added
January 29, 2025HouseFloorActionAuthor added

Citations

 
[
  {
    "analysis": {
      "added": [
        "Introduces a higher licensing fee category for manufacturers of opiate-containing substances."
      ],
      "removed": [
        ""
      ],
      "summary": "This bill references the control of opiate-containing substances relevant to drug manufacturer licensing fees.",
      "modified": [
        "Adjusts the fee structure for several licensing categories, including drugs related to section 152.02."
      ]
    },
    "citation": "152.02",
    "subdivision": "subdivisions 3 to 5"
  }
]